HomeLBRX • NASDAQ
add
LB Pharmaceuticals Inc
Previous close
$21.50
Day range
$21.28 - $23.11
Year range
$13.40 - $23.15
Market cap
563.16M USD
Avg Volume
386.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.25M | -67.38% |
Net income | -3.56M | 74.92% |
Net profit margin | — | — |
Earnings per share | -0.61 | — |
EBITDA | -5.16M | 67.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 314.48M | — |
Total assets | 320.75M | — |
Total liabilities | 10.52M | — |
Total equity | 310.22M | — |
Shares outstanding | 25.30M | — |
Price to book | 1.75 | — |
Return on assets | -7.71% | — |
Return on capital | -8.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.56M | 74.92% |
Cash from operations | -3.37M | 84.69% |
Cash from investing | -44.84M | -255.28% |
Cash from financing | 303.73M | 1,518,560.00% |
Net change in cash | 255.52M | 3,626.45% |
Free cash flow | -941.75K | — |
About
Founded
2015
Website
Employees
16
